Ultomiris (ravulizumab-cwvz) may be safe and effective as a treatment for paroxysmal nocturnal hemoglobinuria (PNH) in pregnant women, a study suggested. Of 19 pregnancies in women treated with Ultomiris, all resulted in live births, compared with four live births out of eight pregnancies previously managed with Soliris…